John M. Hastings - 12 Aug 2022 Form 4 Insider Report for Cardiovascular Systems Inc

Reporting relationship: VP Manufacturing & Operations
Issuer ticker: N/A
Reported as of: 12 Aug 2022
Net transaction value: -$27,090
SEC form: 4
Accepted by SEC: 16 Aug 2022, 20:52:55 UTC
Prior SEC filing: 09 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Andrew Nick as Attorney-in-Fact for John M. Hastings pursuant to Power of Attorney previously filed.

Key filing fact

John M. Hastings filed Form 4 for Cardiovascular Systems Inc on 16 Aug 2022.

Key facts

This page summarizes John M. Hastings's Form 4 filing for Cardiovascular Systems Inc.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 Aug 2022, 20:52.

Change

Previous filing in this sequence was filed on 09 Feb 2022.
Current net transaction value: -$27,090.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CSII transaction

Common Stock

Tax liability

Transaction value: $27,090
Shares: -1,628
Change %: -2.9%
Price: $16.64
Shares after: 53,652
Date: 12 Aug 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of prior restricted stock grants by directing the Company to withhold shares otherwise issuable upon vesting of the previously reported grants.